The Precision Peptide Company Inc.
BPC
CNSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 79.60K | 67.60K | 35.90K | 5.10K | 800.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 79.60K | 67.60K | 35.90K | 5.10K | 800.00 |
| Cost of Revenue | 37.70K | 25.50K | 20.00K | 2.50K | 1.10K |
| Gross Profit | 41.80K | 42.00K | 15.80K | 2.60K | -300.00 |
| SG&A Expenses | 2.63M | 2.47M | 1.55M | 1.11M | 703.20K |
| Depreciation & Amortization | 66.00K | 66.00K | 66.00K | 32.50K | 100.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.78M | 2.61M | 1.66M | 1.16M | 723.30K |
| Operating Income | -2.70M | -2.54M | -1.62M | -1.16M | -722.50K |
| Income Before Tax | -4.34M | -4.19M | -3.29M | -1.20M | -765.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.34 | -4.19 | -3.29 | -1.20 | -0.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.34M | -4.19M | -3.29M | -1.20M | -765.60K |
| EBIT | -2.70M | -2.54M | -1.62M | -1.16M | -722.50K |
| EBITDA | -2.63M | -2.48M | -1.58M | -1.14M | -719.00K |
| EPS Basic | -0.11 | -0.11 | -0.10 | -0.09 | -0.08 |
| Normalized Basic EPS | -0.04 | -0.05 | -0.04 | -0.06 | -0.05 |
| EPS Diluted | -0.11 | -0.11 | -0.10 | -0.09 | -0.08 |
| Normalized Diluted EPS | -0.04 | -0.05 | -0.04 | -0.06 | -0.05 |
| Average Basic Shares Outstanding | 156.69M | 133.13M | 100.35M | 62.88M | 41.14M |
| Average Diluted Shares Outstanding | 156.69M | 133.13M | 100.35M | 62.88M | 41.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |